Macozinone

N/A

Report date: 2024/02/01 20:01:00
NME

Base Information

Drug NameMacozinone
Drug Alias NamePBTZ-169-NCPPBTZ-169
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitors
TargetsFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEcole Polytechnique Federale De Lausanne
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNearmedic Plus Llc
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A